While weve always offered comprehensive weight loss services, were thrilled to include GLP-1 agonist medications that are helping our patients to finally declare victory in their weight loss journeys
Coverage gap (donut hole): You pay 25% of the drug cost until out-of-pocket spending reaches $8,000
The two material categories are not interchangeable
However, the FDA previously announced in February 2025 that the supply issues related to Ozempic and its weight loss counterpart, Wegovy, have been resolved, effectively decreasing the need for compounded alternatives
This applies to all research peptide vendors, not just Simple Peptide
The struggle feels deeply unfair because eating and exercise habits often have not changed, yet the body responds completely differently